WO2012019268A3 - Composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral - Google Patents
Composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral Download PDFInfo
- Publication number
- WO2012019268A3 WO2012019268A3 PCT/BR2011/000294 BR2011000294W WO2012019268A3 WO 2012019268 A3 WO2012019268 A3 WO 2012019268A3 BR 2011000294 W BR2011000294 W BR 2011000294W WO 2012019268 A3 WO2012019268 A3 WO 2012019268A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccine
- immunogenic composition
- leishmaniasis
- test kit
- visceral leishmaniasis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A presente invenção descreve uma composição imunogênica para vacina e teste imunodiagnóstico de Leishmaniose Visceral. Mais especificamente, a invenção compreende uma vacina e um kit para teste imunodiagnóstico de Leishmaniose, desenvolvidos através da identificação, produção e seleção de novos antígenos por meio de análise proteômica, bioinformática, síntese de peptídeos e imunoensaio. A alta especificidade desses antígenos possibilita a realização de uma vacina eficaz contra Leishmaniose e de um teste imunodiagnóstico mais eficiente para a Leishmaniose Visceral canina ou humana.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1006646-2A BRPI1006646A2 (pt) | 2010-08-13 | 2010-08-13 | composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral |
BR014100002830 | 2010-08-13 | ||
BR014110002431 | 2011-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012019268A2 WO2012019268A2 (pt) | 2012-02-16 |
WO2012019268A3 true WO2012019268A3 (pt) | 2012-07-26 |
Family
ID=45936517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2011/000294 WO2012019268A2 (pt) | 2010-08-13 | 2011-08-12 | Composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral |
Country Status (2)
Country | Link |
---|---|
BR (1) | BRPI1006646A2 (pt) |
WO (1) | WO2012019268A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR102013033627B1 (pt) * | 2013-12-27 | 2021-02-09 | Universidade Federal De Minas Gerais | peptídeos sintéticos, método e kit para imunodiagnóstico da leishmaniose visceral canina e das leishmanioses tegumentar e visceral humana |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965142A (en) * | 1995-08-04 | 1999-10-12 | Corixa Corporation | Polypeptides and methods for the detection of L. tropica infection |
WO2006108720A2 (en) * | 2005-04-08 | 2006-10-19 | Institut Pasteur | Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
-
2010
- 2010-08-13 BR BRPI1006646-2A patent/BRPI1006646A2/pt not_active Application Discontinuation
-
2011
- 2011-08-12 WO PCT/BR2011/000294 patent/WO2012019268A2/pt active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965142A (en) * | 1995-08-04 | 1999-10-12 | Corixa Corporation | Polypeptides and methods for the detection of L. tropica infection |
WO2006108720A2 (en) * | 2005-04-08 | 2006-10-19 | Institut Pasteur | Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
Non-Patent Citations (1)
Title |
---|
PEACOCK, CS ET AL.: "Comparative analysis of genomic threre Leishmaria species causing diverse human disease.", NAT GENET., vol. 39, no. 7, 2007, pages 839 - 847 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012019268A2 (pt) | 2012-02-16 |
BRPI1006646A2 (pt) | 2012-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
WO2014089335A3 (en) | Bcma antigen binding proteins | |
EA201790757A1 (ru) | Связывающие антиген cd27l белки | |
EP3792278A3 (en) | Human anti-tau antibodies | |
BR112012009854A8 (pt) | proteínas de ligação de antígeno il-23 humana | |
EA201890548A1 (ru) | Антитела к il-23 | |
IN2014MN00873A (pt) | ||
MX357678B (es) | Moléculas de unión específica a proteína de unión a adn de respuesta transactiva de 43 kda (tdp-43). | |
CR20130128A (es) | Nuevas proteínas de unión a antígenos | |
EA201290254A1 (ru) | Антагонисты il-17a | |
MX353931B (es) | Anticuerpos que se unen a ox40 y sus usos. | |
MX2011006422A (es) | Autoanticuerpos humanos anti-alfa-sinucleina. | |
NZ595707A (en) | Cancer antigen helper peptide | |
NZ601615A (en) | Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor | |
EA201591049A1 (ru) | Способы получения конъюгатов дисульфидсодержащих белков | |
WO2013059524A3 (en) | Antibodies directed against influenza | |
WO2012064836A9 (en) | Methods and compositions for neural disease immunotherapy | |
BR112014008089A2 (pt) | método para diagnosticar o mal de alzheimer, uso do método, e, kit para a realização do método | |
EP2577307A4 (en) | DIAGNOSTIC TEST | |
WO2013132040A3 (en) | In vitro potency assay for protein-based meningococcal vaccines | |
WO2011112670A3 (en) | Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease | |
BR112013023211A2 (pt) | ensaio diagnóstico de anticorpos | |
WO2013122544A3 (en) | IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES | |
WO2012019268A3 (pt) | Composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral | |
WO2011101670A3 (en) | Allergen microarray |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11815939 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11815939 Country of ref document: EP Kind code of ref document: A2 |